Cargando…
Lactiplantibacillus plantarum Y15 alleviate type 2 diabetes in mice via modulating gut microbiota and regulating NF-κB and insulin signaling pathway
Probiotics have been used for the treatment of chronic metabolic diseases, including type 2 diabetes (T2D). However, the mechanisms of antidiabetic effects are not well understood. The object of this study is to assess the antidiabetic effect of Lactiplantibacillus plantarum Y15 isolated from Chines...
Autores principales: | Liu, Yin, Zheng, Shujuan, Cui, Jiale, Guo, Tingting, Zhang, Jingtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853432/ https://www.ncbi.nlm.nih.gov/pubmed/35150432 http://dx.doi.org/10.1007/s42770-022-00686-5 |
Ejemplares similares
-
Metabolomic and Transcriptional Profiling of Oleuropein Bioconversion into Hydroxytyrosol during Table Olive Fermentation by Lactiplantibacillus plantarum
por: Vaccalluzzo, Amanda, et al.
Publicado: (2022) -
Effects of Lactiplantibacillus plantarum 19-2 on immunomodulatory function and gut microbiota in mice
por: Wang, Xiaoran, et al.
Publicado: (2022) -
Lactiplantibacillus plantarum Reduced Renal Calcium Oxalate Stones by Regulating Arginine Metabolism in Gut Microbiota
por: Liu, Yu, et al.
Publicado: (2021) -
Lactiplantibacillus plantarum N-1 improves autism-like behavior and gut microbiota in mouse
por: Qiu, Zhongqing, et al.
Publicado: (2023) -
Lactiplantibacillus plantarum AR113 Exhibit Accelerated Liver Regeneration by Regulating Gut Microbiota and Plasma Glycerophospholipid
por: Xie, Chunliang, et al.
Publicado: (2022)